GLP-1 Hub: Support, Community, and Weight Loss

Send us Fan Mail
What happens to hunger and food noise when someone lowers their GLP-1 dose or stops taking the medication?

In this episode, Ana Reisdorf talks with Calocurb founder and CEO Sarah Kennedy about a unique supplement designed to support appetite regulation by stimulating the body’s natural satiety hormones.

Sarah walks through the reported results of a 24-week clinical trial involving 150 adults. She says the Calocurb group averaged 5.4% weight loss, reduced fat and visceral fat, and maintained skeletal muscle. Ana asks how the study was conducted, how hunger and cravings were measured, what side effects users may experience, and what evidence currently exists for using Calocurb alongside or after GLP-1 medication.

**IN THIS EPISODE**

- How Calocurb was developed from a New Zealand research initiative
- What the new 24-week clinical trial measured and reported
- How researchers measured hunger and food cravings
- The roles of CCK, GLP-1, and PYY in appetite regulation
- When and how Calocurb is designed to be taken
- Possible digestive side effects and the onboarding process
- Where Calocurb might fit alongside or after GLP-1 medication
- What research is still needed for people reducing or stopping GLP-1s
- Potential future studies involving postmenopausal women and adolescents
- Why Sarah describes Calocurb as a tool rather than a magic pill

**ABOUT THE GUEST**

Sarah Kennedy is the founder and CEO of Calocurb, a veterinarian by training, and an experienced nutrition and health-industry executive. During more than 20 years in dietary and animal nutrition, she led Healtheries/Vitaco New Zealand and held senior international and nutrition leadership positions at Fonterra. She is also an MIT Sloan Fellow in Global Leadership and Innovation and has served on the boards of government, private, philanthropic, and publicly listed organizations.

**CONNECT WITH SARAH AND CALOCURB**

Website:
https://calocurb.com

Instagram:
https://www.instagram.com/calocurb

YouTube:
https://www.youtube.com/@calocurb

**SPONSORS**

Johnson Fitness and Wellness offers home fitness equipment, expert guidance, delivery, and professional installation. Shop online and use code GLP1Hub5 for an exclusive offer:
https://www.johnsonfitness.com

Tyde Wellness provides clinician-guided GLP-1 care, nutrition support, hormone therapy, and longevity services. Use code GLP1Hub50 for $50 off your first month:
https://tydewellness.com/GLP1Hub

**CHAPTERS**

00:00 Why reducing calories can increase hunger
00:25 What happens when GLP-1 treatment changes?
01:34 Meet Sarah Kennedy
02:07 How CaloCurb was developed
05:20 What the 24-week trial reported
07:30 Trial design and lifestyle support
09:09 How hunger and cravings were measured
11:16 CCK, GLP-1, and PYY explained
13:16 When and how CaloCurb is used
16:47 Could it fit alongside or after GLP-1s?
19:02 Appetite regulation and weight maintenance
22:12 Side effects and the onboarding process
24:39 Combining CaloCurb with GLP-1 medication
26:33 Future studies and unanswered questions
29:48 Studying appetite support in adolescents
31:11 A tool, not a magic pill
33:59 Where to learn more

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail
Teresa Keever’s first experience with tirzepatide lasted only eight weeks. The fatigue and digestive side effects consumed her weekends, left her barely able to eat, and made the standard dosing schedule feel impossible to sustain.

Six months later, Teresa tried again, this time working with her provider on a lower, slower, split-dose approach. She shares how that personalized strategy changed her experience, helped make the side effects manageable, and supported a loss of more than 50 pounds.

**IN THIS EPISODE**

- Why Teresa stopped tirzepatide after only eight weeks
- How GLP-1 medication changed her understanding of food noise and willpower
- Her experience with compounded medication and split dosing
- Why slower titration made treatment more manageable for her
- The lifestyle changes that became easier after losing weight
- How she approaches protein, exercise, and nutrition without rigid targets
- Why she plans to continue GLP-1 treatment for long-term maintenance
- The importance of personalized care and ongoing medical oversight

**ABOUT THE GUEST**

Teresa Keever is a nurse by background who now works in healthcare administration. After years of navigating weight loss and weight management, she began using a GLP-1 medication and ultimately found a clinician-guided approach that better fit her individual needs. She joins the podcast to share her personal experience with side effects, compounded tirzepatide, split dosing, and long-term treatment.

**SPONSORS**

CaloCurb is a plant-based supplement designed to support appetite control. It is not a replacement for medical care, but it may be one tool to discuss with your healthcare provider. Learn more at https://calocurb.com and use code ANA10 for 10% off.

Tyde Wellness offers GLP-1 programs with licensed providers, personalized dosing support, nutrition guidance, and access to a care team. Visit https://tydewellness.com/GLP1Hub and use code GLP1Hub50 for $50 off your first month.

**CHAPTERS**

00:00 Teresa’s experience with split dosing
00:28 Why she returned to GLP-1 medication
01:34 Meet Teresa Keever
02:17 A lifelong weight-management journey
03:44 Rethinking willpower and food noise
05:06 Insurance, telehealth, and compounded tirzepatide
06:54 Side effects and stopping after eight weeks
09:05 Returning with a slower, split-dose approach
10:28 Teresa’s results and current side effects
11:02 Movement, exercise, nutrition, and protein
14:09 Family reactions, stigma, and glucose changes
16:05 Long-term treatment and maintenance
19:26 Healthcare attitudes, access, and cost
20:50 Combining telehealth with primary care
23:04 What to discuss when side effects are difficult
26:08 Why personalized GLP-1 care matters
28:53 Visualizing medication levels with GLP-1 Plotter
30:49 Hopes for the future of GLP-1 treatment
31:41 Final takeaway and dosing-safety reminder

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail
Losing access to a GLP-1 can happen even when treatment is working exactly as intended. A lower BMI, an insurance change, or an employer facing open-ended costs can suddenly turn a prescription into a maze of denials, prior authorizations, and unexpected expenses.

In this episode, Ana Reisdorf speaks with Jay Bregman, founder and CEO of Andel, about why traditional insurance struggles to cover high-demand medications and how direct-to-employer purchasing could offer another path. Jay explains how fixed employer contributions can make GLP-1 benefits more predictable, why he believes prior authorizations add unnecessary costs, and what patients can do when their coverage is at risk.

They also discuss Medicare access, losing coverage after successful weight loss, options for self-employed people, compounded medications, future GLP-1 competition, and whether access can become more equitable.

**IN THIS EPISODE**

- Why GLP-1 demand creates problems for traditional insurance
- How pharmaceutical middlemen affect medication pricing and access
- What direct-to-employer purchasing means
- Why employers hesitate to fund open-ended GLP-1 coverage
- How fixed employer contributions could make benefits more sustainable
- Why successful treatment and a lower BMI can lead to lost coverage
- The hidden administrative costs of prior authorizations
- What to do if you’re worried about affording your medication
- Options for self-employed people without employer assistance
- Jay’s perspective on Medicare, compounded medications, competition, and equitable access

**ABOUT THE GUEST**

Jay Bregman is the founder and CEO of Andel, a healthcare technology platform that enables high-cost medications like GLP-1s to be more accessible through employer benefits. With more than two decades of experience building and scaling companies, Jay brings a strong understanding of how policy, pricing, and market incentives intersect.

In developing Andel, he has focused on redesigning access pathways for high-demand, high-cost drugs that traditional coverage models fail to accommodate. His perspective on GLP-1 access and employer responsibility has been featured in Inc., STAT News, and Pharmaceutical Executive. He has also spoken at TEDx and Web Summit about business leadership.

Jay appears in this episode in his capacity as Andel’s founder and CEO. His comments about Andel and the pharmaceutical market reflect his experience and commercial perspective.

**CONNECT WITH JAY**

Andel:
https://www.andel.org/

Andel Raises $4.5M for Its Employer-Supported Medication Marketplace:
https://www.prnewswire.com/news-releases/andel-raises-4-5m-for-its-employer-supported-medication-marketplace-302588465.html

Andel Launches New Direct-to-Employer Medication Platform:
https://www.prnewswire.com/news-releases/andel-launches-new-direct-to-employer-medication-platform-to-make-glp-1s-affordable-for-millions-302709372.html

**SPONSORS**

This episode includes sponsored messages from Johnson Fitness & Wellness and gutzy Organic.

Johnson Fitness & Wellness offers strength-training equipment, cardio machines, recovery products, and expert guidance for a range of fitness levels, spaces, and budgets. Visit https://www.johnsonfitness.com/ and use code GLP1Hub5 for an exclusive offer for GLP-1 Hub listeners.

gutzy Organic makes refrigerated fruit-and-vegetable pouches with prebiotic fiber for convenient, produce-based snacking.

Learn more at https://gutzyorganic.com/

**JOIN THE 21-DAY MEAL CONFIDENCE CHALLENGE**

Starting August 17, the GLP-1 Hub Membership’s 21-Day Meal Confidence Challenge will teach you a simple framework for making food decisions at restaurants, parties, potlucks, vacations, and in everyday life.

Join for $5:
https://glp-1hub.com/challenge

**CHAPTERS**

00:00 When successful treatment costs you coverage
00:21 Why GLP-1 access is getting harder
01:45 Meet Jay Bregman
02:16 How direct-to-employer purchasing works
03:05 Why medication pricing is so complicated
07:24 Why health plans are dropping GLP-1 coverage
08:59 Why employers hesitate to pay long term
09:48 Fixed employer contributions explained
10:46 Long-term health versus short-term employment
12:47 Sponsor: Johnson Fitness & Wellness
14:06 Medicare access and coverage uncertainty
16:03 Losing coverage after lowering your BMI
16:54 The hidden cost of prior authorizations
18:28 What to do if you’re worried about losing access
20:07 Options for self-employed patients
20:12 Competition and the future of GLP-1 pricing
23:13 Can GLP-1 access become more equitable?
24:27 Sponsor: gutzy Organic
25:05 The future of compounded GLP-1s
28:11 Where GLP-1 access could be in five years
29:10 Connect with Andel
30:13 The 21-Day Meal Confidence Challenge

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail
Losing weight with a GLP-1 is only part of the picture. Without regular movement and strength training, losing muscle can affect how you feel today, and your ability to stay active and independent in the years ahead.

In this episode, Ana talks with fitness-industry veteran Craig Lewin about why maintaining strength matters during GLP-1 weight loss and how beginners can start without feeling intimidated. Craig shares approachable options ranging from walking and resistance bands to adjustable dumbbells and home gyms, along with advice for choosing exercise equipment that fits your abilities, limitations, goals, and lifestyle.

They also discuss the importance of finding a form of movement you genuinely enjoy, building accountability, and preventing your new equipment from becoming an expensive clothes rack.

**IN THIS EPISODE**

- Why strength training has become a bigger priority in fitness and healthcare
- How GLP-1 weight loss can affect muscle, strength, and everyday function
- Why maintaining muscle is especially important as we age
- Simple ways to begin with walking, resistance bands, or adjustable dumbbells
- How a personalized fitness assessment can account for your goals and limitations
- Choosing equipment you will realistically use
- How follow-up, accountability, and social connection can support consistency
- Why strength is about independence and quality of life—not only appearance
- How to find Johnson Fitness & Wellness stores and support

**ABOUT THE GUEST**

Born in Zimbabwe in 1977, Craig Lewin immigrated to the United States with his family in 1984 and grew up in Dallas, Texas. He began his career in the fitness industry at age 16 as a cashier and went on to build more than three decades of experience in fitness industry.

In 2010, Craig became a partner in a 21-location fitness retail business in Texas. After selling the business at the end of 2021, he joined Johnson Fitness & Wellness, where he now serves as Executive Vice President of the world’s largest specialty fitness retailer.

Craig met his wife while attending the University of Texas, and they have four sons, including twins, ranging in age from 15 to 22. He describes his personal and professional journey as living the American Dream. His firsthand familiarity with the benefits and challenges associated with GLP-1 use has strengthened his commitment to helping people protect or rebuild their strength through accessible, sustainable exercise.

**CONNECT WITH CRAIG**

Johnson Fitness & Wellness:
https://www.johnsonfitness.com

Instagram:
https://www.instagram.com/johnson.fitness

**SPONSOR**

This episode is sponsored by Johnson Fitness & Wellness, who specializes in home fitness, strength training, and helping beginners find appropriate equipment. Learn more or find a nearby store:
https://www.johnsonfitness.com

Tyde Wellness offers clinician-guided GLP-1 programs with personalized dosing, nutrition support, and access to a care team. Visit https://tydewellness.com/GLP1Hub and use code GLP1Hub50 for $50 off your first month. Eligibility and treatment are determined by a licensed healthcare provider. Individual results vary.

**CHAPTERS**

00:00 Why Exercise Matters for the Future
00:28 Strength Training During GLP-1 Weight Loss
01:45 Meet Craig Lewin
03:10 Why Strength Training Has Grown
06:17 GLP-1s, Weight Loss, and Muscle
09:36 Protecting Strength as We Age
12:49 Simple Ways for Beginners to Start
17:23 Getting a Personalized Fitness Assessment
19:54 Choosing Equipment and Building a Plan
23:45 Keeping Equipment from Collecting Dust
26:52 Finding the Motivation That Works for You
29:16 Exercise, Independence, and Quality of Life
33:12 Johnson Fitness & Wellness Resources
36:04 GLP-1 Hub Closing and Food Challenge

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.

Send us Fan Mail
If you’ve reached your goal weight on a GLP-1, you may be wondering what comes next. Do you stay on the same dose indefinitely, move to a lower dose, or gradually taper off?

Ana speaks with Henrik Gudbergsen, MD, PhD, about the emerging evidence around personalized GLP-1 dosing and structured tapering. They examine what early observational research suggests, why lifestyle and behavioral support may matter during maintenance, and why stopping medication will not be appropriate, or possible, for everyone.

**IN THIS EPISODE**

- Why the least effective dose may be more appropriate than automatically increasing to the maximum
- How Embla’s gradual GLP-1 tapering approach works
- What early observational data suggests about maintaining weight after tapering
- Why nutrition, exercise, coaching, CBT, and acceptance and commitment therapy are part of the program
- Whether most people should expect to remain on GLP-1 medication long term
- How insurance coverage and cost can limit personalized dosing
- Why GLP-1 prescribing differs between Denmark and the United States
- How future medications, genetics, health conditions, and the gut microbiome may shape more individualized treatment

**ABOUT THE GUEST**

Henrik Rindel Gudbergsen, MD, PhD, is the medical lead and advisor at Embla, a digital weight-care company combining low-dose GLP-1 treatment, behavioral coaching, and digital tools. He is a practicing physician, associate professor, and principal investigator on anti-obesity medication trials, with a PhD in medical imaging and obesity research.

Henrik has spent more than 15 years at the intersection of clinical medicine, pharmaceuticals, and digital health. His previous experience includes roles at Novo Nordisk, Radiometer, Philips Healthcare, and IBM Watson Health, along with board-level experience in software as a medical device.

**CONNECT WITH HENRIK**

Embla:
https://www.joinembla.com/

Henrik’s YouTube channel:
https://www.youtube.com/channel/UCMdA5N4TeytPYmbfXjEPJDA

Read the GLP-1 study discussed in this episode:
https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.70096

**SPONSORS**

This episode includes messages from:

gutzy Organic—organic fruit and vegetable pouches with 8 grams of fiber:
https://gutzyorganic.com/

Johnson Fitness & Wellness—fitness equipment, expert guidance, delivery, and professional installation for your home workout space:
https://www.johnsonfitness.com/
Use code GLP1Hub5 for an exclusive GLP-1 Hub listener offer.

**CHAPTERS**

00:00 Can you taper off a GLP-1?
00:28 Episode introduction
01:47 Meet Henrik Rindel Gudbergsen
04:26 Why Embla uses the least effective dose
07:18 What the early tapering data showed
10:07 Behavioral support beyond diet and exercise
11:14 Sponsor: gutzy Organic
11:52 Why human coaching matters
13:16 Can most people stop GLP-1 medications?
18:02 Insurance barriers and personalized dosing
20:31 New real-world research from Denmark
23:28 Sponsor: Johnson Fitness & Wellness
24:43 How dosing practices differ between Denmark and the U.S.
26:07 The future of personalized obesity treatment
28:03 How Embla combines medication and coaching
29:41 GLP-1 Hub membership and closing

MORE FROM GLP-1 HUB
📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com

🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show.

🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com
📷 Follow on Instagram: @glp1hub
📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub
*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.
*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.